Eugenol-rich Fraction of Syzygium aromaticum (Clove) Reverses Biochemical and Histopathological Changes in Liver Cirrhosis and Inhibits Hepatic Cell Proliferation
Dried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound that can protect liver against injury. Clove, besides eugenol, also contains other pharmacologically active phytochemicals such as β-sitosterol and ascorbic acid. This study reports the e...
Saved in:
Published in: | Journal of cancer prevention Vol. 19; no. 4; pp. 288 - 300 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Korea (South)
Korean Society of Cancer Prevention
01-12-2014
대한암예방학회 |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Dried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound that can protect liver against injury. Clove, besides eugenol, also contains other pharmacologically active phytochemicals such as β-sitosterol and ascorbic acid. This study reports the effect of eugenol-rich fraction (ERF) of clove on liver cirrhosis induced by thioacetamide.
Cirrhosis of the liver, which predisposes to hepatocellular carcinoma, was induced by administering thioacetamide (0.03%) in drinking water for 16 weeks. Cirrhotic animals were divided into two groups; the treated group was administered ERF for 9 weeks, one week after discontinuation of thioacetamide, while the other group received normal saline for a similar duration of time.
The treatment with ERF, as determined by histopathology and through a battery of biochemical markers of hepatic injury, oxidative stress and drug metabolizing enzymes, significantly ameliorated the signs of liver cirrhosis. It lowered the elevated levels of alkaline phosphatase, γ-glutamyl transferase and other biochemical changes in liver cirrhosis. Histopathology of the liver corroborated the effect of ERF with biochemical findings. ERF treatment further inhibited cell proliferation, as demonstrated by reduced [(3)H]-thymidine uptake.
Data provide evidence supporting the protective action of ERF on liver cirrhosis. The study assumes significance because cirrhosis predisposes the liver to cancer, which is characterized by abnormal cell proliferation. ERF in this study is reported to inhibit hepatic cell proliferation and at the same time decrease oxidative stress, which might be the mechanism of protection against liver cirrhosis. |
---|---|
AbstractList | Dried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound that can protect liver against injury. Clove, besides eugenol, also contains other pharmacologically active phytochemicals such as β-sitosterol and ascorbic acid. This study reports the effect of eugenol-rich fraction (ERF) of clove on liver cirrhosis induced by thioacetamide.
Cirrhosis of the liver, which predisposes to hepatocellular carcinoma, was induced by administering thioacetamide (0.03%) in drinking water for 16 weeks. Cirrhotic animals were divided into two groups; the treated group was administered ERF for 9 weeks, one week after discontinuation of thioacetamide, while the other group received normal saline for a similar duration of time.
The treatment with ERF, as determined by histopathology and through a battery of biochemical markers of hepatic injury, oxidative stress and drug metabolizing enzymes, significantly ameliorated the signs of liver cirrhosis. It lowered the elevated levels of alkaline phosphatase, γ-glutamyl transferase and other biochemical changes in liver cirrhosis. Histopathology of the liver corroborated the effect of ERF with biochemical findings. ERF treatment further inhibited cell proliferation, as demonstrated by reduced [(3)H]-thymidine uptake.
Data provide evidence supporting the protective action of ERF on liver cirrhosis. The study assumes significance because cirrhosis predisposes the liver to cancer, which is characterized by abnormal cell proliferation. ERF in this study is reported to inhibit hepatic cell proliferation and at the same time decrease oxidative stress, which might be the mechanism of protection against liver cirrhosis. BACKGROUNDDried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound that can protect liver against injury. Clove, besides eugenol, also contains other pharmacologically active phytochemicals such as β-sitosterol and ascorbic acid. This study reports the effect of eugenol-rich fraction (ERF) of clove on liver cirrhosis induced by thioacetamide. METHODSCirrhosis of the liver, which predisposes to hepatocellular carcinoma, was induced by administering thioacetamide (0.03%) in drinking water for 16 weeks. Cirrhotic animals were divided into two groups; the treated group was administered ERF for 9 weeks, one week after discontinuation of thioacetamide, while the other group received normal saline for a similar duration of time. RESULTSThe treatment with ERF, as determined by histopathology and through a battery of biochemical markers of hepatic injury, oxidative stress and drug metabolizing enzymes, significantly ameliorated the signs of liver cirrhosis. It lowered the elevated levels of alkaline phosphatase, γ-glutamyl transferase and other biochemical changes in liver cirrhosis. Histopathology of the liver corroborated the effect of ERF with biochemical findings. ERF treatment further inhibited cell proliferation, as demonstrated by reduced [(3)H]-thymidine uptake. CONCLUSIONSData provide evidence supporting the protective action of ERF on liver cirrhosis. The study assumes significance because cirrhosis predisposes the liver to cancer, which is characterized by abnormal cell proliferation. ERF in this study is reported to inhibit hepatic cell proliferation and at the same time decrease oxidative stress, which might be the mechanism of protection against liver cirrhosis. Background:Dried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound thatcan protect liver against injury. Clove, besides eugenol, also contains other pharmacologically active phytochemicals such as β-sitosteroland ascorbic acid. This study reports the effect of eugenol-rich fraction (ERF) of clove on liver cirrhosis induced by thioacetamide. Methods:Cirrhosis of the liver, which predisposes to hepatocellular carcinoma, was induced by administering thioacetamide (0.03%)in drinking water for 16 weeks. Cirrhotic animals were divided into two groups; the treated group was administered ERF for 9 weeks,one week after discontinuation of thioacetamide, while the other group received normal saline for a similar duration of time. Results:The treatment with ERF, as determined by histopathology and through a battery of biochemical markers of hepatic injury, oxidativestress and drug metabolizing enzymes, significantly ameliorated the signs of liver cirrhosis. It lowered the elevated levels ofalkalinephosphatase, γ-glutamyl transferase and other biochemical changes in liver cirrhosis. Histopathology of the liver corroborated the effectof ERF with biochemical findings. ERF treatment further inhibited cell proliferation, as demonstrated by reduced [3H]-thymidine uptake. Conclusions:Data provide evidence supporting the protective action of ERF on liver cirrhosis. The study assumes significance becausecirrhosis predisposes the liver to cancer, which is characterized by abnormal cell proliferation. ERF in this study is reportedto inhibithepatic cell proliferation and at the same time decrease oxidative stress, which might be the mechanism of protection against liver cirrhosis. KCI Citation Count: 0 |
Author | Shinkafi, Tijjani Salihu Sahin, Kazim Kucuk, Omer Ali, Shakir Mahmood, Amena Routray, Indusmita Prasad, Ram |
AuthorAffiliation | 3 Winship Cancer Institute, Emory University, Atlanta, Georgia, USA 2 Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey 1 Department of Biochemistry, Faculty of Science, Jamia Hamdard, Hamdard Nagar, New Delhi, India |
AuthorAffiliation_xml | – name: 2 Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey – name: 1 Department of Biochemistry, Faculty of Science, Jamia Hamdard, Hamdard Nagar, New Delhi, India – name: 3 Winship Cancer Institute, Emory University, Atlanta, Georgia, USA |
Author_xml | – sequence: 1 givenname: Shakir surname: Ali fullname: Ali, Shakir organization: Department of Biochemistry, Faculty of Science, Jamia Hamdard, Hamdard Nagar, New Delhi, India – sequence: 2 givenname: Ram surname: Prasad fullname: Prasad, Ram organization: Department of Biochemistry, Faculty of Science, Jamia Hamdard, Hamdard Nagar, New Delhi, India – sequence: 3 givenname: Amena surname: Mahmood fullname: Mahmood, Amena organization: Department of Biochemistry, Faculty of Science, Jamia Hamdard, Hamdard Nagar, New Delhi, India – sequence: 4 givenname: Indusmita surname: Routray fullname: Routray, Indusmita organization: Department of Biochemistry, Faculty of Science, Jamia Hamdard, Hamdard Nagar, New Delhi, India – sequence: 5 givenname: Tijjani Salihu surname: Shinkafi fullname: Shinkafi, Tijjani Salihu organization: Department of Biochemistry, Faculty of Science, Jamia Hamdard, Hamdard Nagar, New Delhi, India – sequence: 6 givenname: Kazim surname: Sahin fullname: Sahin, Kazim organization: Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey – sequence: 7 givenname: Omer surname: Kucuk fullname: Kucuk, Omer organization: Winship Cancer Institute, Emory University, Atlanta, Georgia, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25574464$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001948992$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNpVUsFu1DAUtFARLaU_wAH5WA4JtuPY8QWpRC27aCWqUs6W1-skpokd7OxKy-fwpXizsMBpnvxm3jzrzUtw5rwzALzGKMclLdC7T_V9ThCmORY5zUlVPQMXJEFWsJKfnWoqzsFVjN8QQrgomRDkBTgnZckpZfQC_Lzdtsb5PgtWd_AuKD1Z76Bv4Jf9j31rtwNUwQ9qsjqV13Xvd-YtfDA7E6KJ8IP1ujOD1aqHym3gwsbJj2rqfO_b-bXulGsT0zq4skkFaxtC56ONs2DpOru2U4QLMx5MYG36Ht4H39vGBHVY5hV43qg-mqvfeAm-3t0-1ots9fnjsr5ZZbogospUoxQSSishNDaiIJRWlJMGa4EZwg3CpVAbxguFKV2biiGtGebMME045-viElwf57rQyCdtpVd2xtbLpyBvHh6XUhBGeZmo74_UcbsezEYbNwXVyzHYQYX9LPy_42yXxuwkJVUpGPrrNQb_fWviJAcbdfq6csZvo8SMlvxwoipRyZGqg48xmOZkg5GcoyBTFOQhChILSWW6exK9-XfBk-TP4Ytf5fS0DQ |
CitedBy_id | crossref_primary_10_1016_j_jrras_2018_08_003 crossref_primary_10_1080_19390211_2017_1330301 crossref_primary_10_3390_molecules21010113 crossref_primary_10_3390_tropicalmed8050253 crossref_primary_10_1016_j_lfs_2018_11_031 crossref_primary_10_1007_s10989_018_09801_3 crossref_primary_10_3389_fnut_2022_1039753 crossref_primary_10_14814_phy2_15584 crossref_primary_10_3390_biom10020202 crossref_primary_10_1002_mnfr_202300793 crossref_primary_10_1016_j_biopha_2021_111588 crossref_primary_10_1016_j_sjbs_2016_01_029 crossref_primary_10_1016_j_sjbs_2015_08_011 crossref_primary_10_2174_2215083810666230330161740 crossref_primary_10_1016_j_actpha_2017_07_012 crossref_primary_10_1111_jpn_13032 crossref_primary_10_1016_j_bpc_2015_07_007 crossref_primary_10_3389_fmicb_2019_01244 crossref_primary_10_1093_jpp_rgab032 crossref_primary_10_21931_RB_CSS_2023_08_01_71 |
Cites_doi | 10.1021/jf030247q 10.1271/bbb.62.1201 10.1016/0952-3278(91)90070-L 10.1179/135100004225004742 10.1016/S0021-9258(17)36428-1 10.1002/cbf.1082 10.1007/978-1-60327-029-8_10 10.1093/carcin/7.11.1865 10.1016/0006-2952(84)90353-8 10.1111/jphp.12197 10.1021/jf048076s 10.1023/A:1020822610085 10.1002/ptr.2124 10.1016/j.febslet.2007.01.044 10.1002/mc.20601 10.1016/S0021-9258(19)44083-0 10.1007/s12272-011-0516-2 10.1126/science.109.2824.144 10.1016/S0021-9258(19)41206-4 10.1016/0952-3278(93)90116-E 10.1016/j.lfs.2008.01.011 10.1016/S0925-4439(01)00030-8 10.1021/np50085a029 10.1002/jat.1057 10.1002/jsfa.4521 10.1016/0300-483X(95)03177-H 10.1023/A:1018817600238 10.1016/S0006-2952(03)00419-2 10.1038/206093a0 10.3109/1547691X.2014.912698 10.1016/j.tox.2009.12.018 10.1016/j.fitote.2013.12.023 10.1016/S0098-2997(00)00004-2 10.1002/hep.20683 10.1016/S0378-8741(98)00121-4 10.1074/jbc.272.48.30129 10.1016/0162-3109(86)90002-0 10.1016/S0021-9258(18)57394-4 10.3109/1547691X.2013.832444 10.1159/000136485 10.1089/jmf.2013.0033 10.1136/jcp.7.4.322 10.1016/S0168-8278(01)00163-5 10.1097/00004836-200211002-00003 10.1007/s12349-010-0033-8 10.3390/molecules17066290 10.1248/cpb.40.401 10.1016/j.jhep.2009.02.023 10.1186/1471-2407-13-600 10.1007/s11418-014-0839-7 10.1358/mf.2010.32.10.1522224 10.1073/pnas.71.10.3879 10.1111/j.1472-8206.2010.00900.x 10.1007/s12272-011-0320-z 10.1016/S0944-7113(11)80044-9 10.1053/j.gastro.2011.12.044 |
ContentType | Journal Article |
Copyright | Copyright © 2014 Korean Society of Cancer Prevention 2014 |
Copyright_xml | – notice: Copyright © 2014 Korean Society of Cancer Prevention 2014 |
DBID | NPM AAYXX CITATION 7X8 5PM ACYCR |
DOI | 10.15430/JCP.2014.19.4.288 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2288-3657 |
EndPage | 300 |
ExternalDocumentID | oai_kci_go_kr_ARTI_926475 10_15430_JCP_2014_19_4_288 25574464 |
Genre | Journal Article |
GroupedDBID | 5-W 8JR ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL DIK HYE KQ8 M48 NPM OK1 PGMZT RPM AAYXX CITATION 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c3298-afaa09aca99c1e932448472f1c91601f0159ad673a144be860cc6176e6c2777b3 |
IEDL.DBID | RPM |
ISSN | 2288-3649 |
IngestDate | Tue Nov 21 21:49:58 EST 2023 Tue Sep 17 21:19:20 EDT 2024 Fri Oct 25 09:27:36 EDT 2024 Thu Sep 26 17:23:39 EDT 2024 Sat Sep 28 07:55:46 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Cell proliferation Cirrhosis Liver Clove Fibrosis |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3298-afaa09aca99c1e932448472f1c91601f0159ad673a144be860cc6176e6c2777b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-001752.2014.19.4.004 http://dx.doi.org/10.15430/JCP.2014.19.4.288 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285960/ |
PMID | 25574464 |
PQID | 1645774468 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_926475 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4285960 proquest_miscellaneous_1645774468 crossref_primary_10_15430_JCP_2014_19_4_288 pubmed_primary_25574464 |
PublicationCentury | 2000 |
PublicationDate | 20141201 |
PublicationDateYYYYMMDD | 2014-12-01 |
PublicationDate_xml | – month: 12 year: 2014 text: 20141201 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of cancer prevention |
PublicationTitleAlternate | J Cancer Prev |
PublicationYear | 2014 |
Publisher | Korean Society of Cancer Prevention 대한암예방학회 |
Publisher_xml | – name: Korean Society of Cancer Prevention – name: 대한암예방학회 |
References | 23196096 - Phytomedicine. 1995 Jul;2(1):23-8 10978499 - Mol Aspects Med. 2000 Jun;21(3):49-98 24099633 - J Immunotoxicol. 2014 Jul-Sep;11(3):238-45 24611461 - J Med Food. 2014 Jul;17(7):764-71 20036707 - Toxicology. 2010 Feb 9;268(3):204-12 9692204 - Biosci Biotechnol Biochem. 1998 Jun;62(6):1201-4 12963494 - Biochem Pharmacol. 2003 Sep 15;66(6):1061-6 16170979 - Indian J Physiol Pharmacol. 2005 Apr;49(2):125-31 3445704 - Z Versuchstierkd. 1987;30(5-6):165-80 9374492 - J Biol Chem. 1997 Nov 28;272(48):30129-34 24873744 - J Immunotoxicol. 2015 Apr-Jun;12(2):124-31 4735346 - J Biol Chem. 1973 Apr 25;248(8):2836-44 8574354 - Free Radic Res. 1995 Dec;23 (6):617-27 9454821 - J Pharmacol Exp Ther. 1998 Feb;284(2):728-35 6145422 - Biochem Pharmacol. 1984 Jun 1;33(11):1801-7 20043298 - Mol Carcinog. 2010 Mar;49(3):290-301 24330704 - BMC Cancer. 2013 Dec 13;13:600 24789168 - J Nat Med. 2014 Jul;68(3):567-75 15841469 - Hepatology. 2005 May;41(5):1074-84 15769115 - J Agric Food Chem. 2005 Mar 23;53(6):1927-33 10197752 - J Ethnopharmacol. 1999 Feb;64(2):167-71 24418657 - Fitoterapia. 2014 Mar;93:150-62 17380552 - Phytother Res. 2007 Jun;21(6):501-6 3769135 - Carcinogenesis. 1986 Nov;7(11):1865-70 8321872 - Prostaglandins Leukot Essent Fatty Acids. 1993 May;48(5):363-72 22634840 - Molecules. 2012 May 25;17(6):6290-304 3546191 - Immunopharmacology. 1986 Dec;12(3):187-92 15027095 - Cell Biochem Funct. 2004 Mar-Apr;22(2):67-79 17672214 - Biomed Environ Sci. 2007 Jun;20(3):226-34 4831804 - Pharmacology. 1974;11(3):151-69 237922 - J Biol Chem. 1975 Jul 25;250(14):5475-80 11335101 - Biochim Biophys Acta. 2001 Apr 30;1536(1):21-30 1402962 - J Nat Prod. 1992 Jul;55(7):999-1003 21225006 - Methods Find Exp Clin Pharmacol. 2010 Dec;32(10):713-9 11682029 - J Hepatol. 2001 Oct;35(4):457-64 17275817 - FEBS Lett. 2007 Feb 20;581(4):749-56 2011614 - Prostaglandins Leukot Essent Fatty Acids. 1991 Jan;42(1):73-81 24372555 - J Pharm Pharmacol. 2014 May;66(5):733-46 22240484 - Gastroenterology. 2012 Apr;142(4):938-46 18914082 - J Biol Chem. 1948 May;174(1):257-64 21547684 - Arch Pharm Res. 2011 Mar;34(3):501-7 12394210 - J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S79-85 14558756 - J Agric Food Chem. 2003 Oct 22;51(22):6413-22 17759170 - Science. 1949 Feb 11;109(2824):144-6 18313080 - Life Sci. 2008 Mar 26;82(13-14):780-8 21105912 - Fundam Clin Pharmacol. 2011 Dec;25(6):708-16 21656368 - Arch Pharm Res. 2011 May;34(5):821-8 4308738 - J Biol Chem. 1969 Jul 25;244(14):3855-63 21725979 - J Sci Food Agric. 2011 Dec;91(15):2777-84 13286357 - J Clin Pathol. 1954 Nov;7(4):322-6 19398228 - J Hepatol. 2009 Jun;50(6):1102-11 15231065 - Redox Rep. 2004;9(2):105-10 15856529 - J Appl Toxicol. 2005 May-Jun;25(3):218-23 20013178 - Methods Mol Biol. 2010;610:165-80 4139704 - Proc Natl Acad Sci U S A. 1974 Oct;71(10):3879-82 1606636 - Chem Pharm Bull (Tokyo). 1992 Feb;40(2):401-5 8571392 - Toxicology. 1996 Jan 8;106(1-3):197-206 9286239 - Dig Dis Sci. 1997 Aug;42(8):1715-23 12482026 - Mol Cell Biochem. 2002 Dec;241(1-2):61-7 ref13 ref57 ref12 ref56 ref15 ref59 ref14 ref58 ref53 ref52 ref11 ref55 ref10 ref54 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref64 ref63 ref22 ref21 ref65 ref28 ref27 ref29 ref60 ref62 ref61 |
References_xml | – ident: ref11 doi: 10.1021/jf030247q – ident: ref28 doi: 10.1271/bbb.62.1201 – ident: ref1 – ident: ref7 doi: 10.1016/0952-3278(91)90070-L – ident: ref60 doi: 10.1179/135100004225004742 – ident: ref37 doi: 10.1016/S0021-9258(17)36428-1 – ident: ref20 – ident: ref43 – ident: ref23 doi: 10.1002/cbf.1082 – ident: ref50 doi: 10.1007/978-1-60327-029-8_10 – ident: ref40 doi: 10.1093/carcin/7.11.1865 – ident: ref35 doi: 10.1016/0006-2952(84)90353-8 – ident: ref2 doi: 10.1111/jphp.12197 – ident: ref27 doi: 10.1021/jf048076s – ident: ref59 doi: 10.1023/A:1020822610085 – ident: ref10 doi: 10.1002/ptr.2124 – ident: ref58 doi: 10.1016/j.febslet.2007.01.044 – ident: ref52 doi: 10.1002/mc.20601 – ident: ref31 doi: 10.1016/S0021-9258(19)44083-0 – ident: ref17 – ident: ref13 – ident: ref55 doi: 10.1007/s12272-011-0516-2 – ident: ref32 doi: 10.1126/science.109.2824.144 – ident: ref34 doi: 10.1016/S0021-9258(19)41206-4 – ident: ref44 – ident: ref12 doi: 10.1016/0952-3278(93)90116-E – ident: ref29 doi: 10.1016/j.lfs.2008.01.011 – ident: ref49 doi: 10.1016/S0925-4439(01)00030-8 – ident: ref6 doi: 10.1021/np50085a029 – ident: ref9 doi: 10.1002/jat.1057 – ident: ref24 doi: 10.1002/jsfa.4521 – ident: ref45 doi: 10.1016/0300-483X(95)03177-H – ident: ref46 doi: 10.1023/A:1018817600238 – ident: ref25 doi: 10.1016/S0006-2952(03)00419-2 – ident: ref41 doi: 10.1038/206093a0 – ident: ref61 doi: 10.3109/1547691X.2014.912698 – ident: ref4 doi: 10.1016/j.tox.2009.12.018 – ident: ref16 – ident: ref33 – ident: ref3 doi: 10.1016/j.fitote.2013.12.023 – ident: ref54 doi: 10.1016/S0098-2997(00)00004-2 – ident: ref64 doi: 10.1002/hep.20683 – ident: ref5 doi: 10.1016/S0378-8741(98)00121-4 – ident: ref26 doi: 10.1074/jbc.272.48.30129 – ident: ref18 doi: 10.1016/0162-3109(86)90002-0 – ident: ref38 doi: 10.1016/S0021-9258(18)57394-4 – ident: ref47 doi: 10.3109/1547691X.2013.832444 – ident: ref39 doi: 10.1159/000136485 – ident: ref19 doi: 10.1089/jmf.2013.0033 – ident: ref30 doi: 10.1136/jcp.7.4.322 – ident: ref56 doi: 10.1016/S0168-8278(01)00163-5 – ident: ref42 doi: 10.1097/00004836-200211002-00003 – ident: ref48 doi: 10.1007/s12349-010-0033-8 – ident: ref65 doi: 10.3390/molecules17066290 – ident: ref14 doi: 10.1248/cpb.40.401 – ident: ref22 doi: 10.1016/j.jhep.2009.02.023 – ident: ref51 doi: 10.1186/1471-2407-13-600 – ident: ref62 doi: 10.1007/s11418-014-0839-7 – ident: ref57 doi: 10.1358/mf.2010.32.10.1522224 – ident: ref36 doi: 10.1073/pnas.71.10.3879 – ident: ref53 doi: 10.1111/j.1472-8206.2010.00900.x – ident: ref15 doi: 10.1007/s12272-011-0320-z – ident: ref8 – ident: ref63 doi: 10.1016/S0944-7113(11)80044-9 – ident: ref21 doi: 10.1053/j.gastro.2011.12.044 |
SSID | ssj0001356992 |
Score | 1.9446028 |
Snippet | Dried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound that can protect liver against injury. Clove,... BACKGROUNDDried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound that can protect liver against... Background:Dried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an antioxidant and antiinflammatory compound thatcan protect liver against... |
SourceID | nrf pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 288 |
SubjectTerms | Original 예방의학 |
Title | Eugenol-rich Fraction of Syzygium aromaticum (Clove) Reverses Biochemical and Histopathological Changes in Liver Cirrhosis and Inhibits Hepatic Cell Proliferation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25574464 https://search.proquest.com/docview/1645774468 https://pubmed.ncbi.nlm.nih.gov/PMC4285960 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001948992 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 대한암예방학회지, 2014, 19(4), , pp.288-300 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELXonrggEF9lWWQkDiCU1HEcOz5CaNVFgCoWJG6W4zrbaNtklWwOuz-HX8pM0qy2iBOnVIqdpH2T-E365g0hb3iaFDFfRwEsD3kgOIsDIEdRkFsJ5DWXay6xOHl5pr79Sj_N0SYnGWthetG-y8uw2u7Cqtz02srLnZuNOrHZ6msm0HVNstmETIAb3knR-xcrcSJ13wyZc4iCWAq9L5ZJRMxmn7MVCrpEGOlQhDAC7YCTREFaJA7WpknVFP-inX-rJ-8sR4uH5MGeR9IPw_U-Ivd89Zj8nnfouboN4OG2oYtmKFqgdUHPrm-uz8tuR21T9yat8PFthvrNd_S7R2mGb-nHEttn9f4B1FZr2luIYMvi8QFJh1qElpYV_YKCDpqVTbOp27LtJ5xWmzIvr1q69CjUdjTz2y1dYWOgwg-h9oT8XMx_ZMtg34QhcDHXaWALa5m2zmrtIg9sD_I5oXgROSCWLCqATmi7liq2kJrlPpXMOWBF0kvHlVJ5_JQcVXXlnxOKXjMslyzOmRC2ENYxbpUHApYCiZBqSt6PP7-5HLw2DOYoiJsB3AziZiJthAHcpuQ1IGQuXGnQIhu357W5aAwkAqdGA9FTCYwZ8TNw2-B_IbbyddcayBIThaDDcZ4NeN6ecwyHKVEHSN8OwPMd7oFI7a2595H54r9nHpP7-C0HwcxLcnTVdP6ETNp196oP8z98wAD7 |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj5swELaa7aG99KE-Nn26Ug-tKogBY8OxpYmSNruKulupN8sYs0GbwAqWw_bn9Jd2BsJqU_W0J5Bsg6wZ29_AN98Q8t6PwjzwM8-B4yF1uM8CB8CR56RaAHhNReYLTE6en8jjX9HXKcrkhEMuTEfaN2nhlputWxbrjlt5sTWTgSc2WR0lHFXXBJuMyF1Yr4zdCNK7TytBKOKuHLLvgx8Egse7dJmQB2zyLVkhpYu7XuxyF3qgIHAYSgiM-N7pNCrr_H_A81_-5I0DafbwllN5RB7sECj93Dc_Jnds-YT8mbao1rpxYFtc01ndpzvQKqcnV7-vzop2S3VddfKucPshQebnR_rDIqnDNvRLgYW3OuUBqsuMduIjWOx42Fppn8XQ0KKkS6SC0KSo63XVFE03YFGui7S4bOjcIsXb0MRuNnSFJYVy2zvpU_JzNj1N5s6ufINjAj-OHJ1rzWJtdBwbzwJOhEiQSz_3DEBS5uUARGKdCRloCOpSGwlmDOApYYXxpZRp8IwclFVpDwlFlRqWChakjHOdc22Yr6UF6BYB_BByTD4NZlMXvUqHwugG7a3A3grtrbxYcQX2HpN3YFl1bgqF4tp4PavUea0ghFioGCCiDKHPYHcFCw7_oujSVm2jIL4MJToLPOd57wfX7xzcaEzknodcd8D37beAY3Si3jtHeHHrkW_Jvfnp0VItF8ffX5L7OOOedvOKHFzWrX1NRk3WvumWyl_wthaF |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELboIiEuPMSrPI3EAYTSOo5jJ0fItmphWVUsSNwsx3G20bZJlWwPy8_hlzKTNNUWcYJTImUcy5qx_U3y-RtC3vAozAOe-R5sD6knOAs8AEe-lxoJ4DWVGZd4OHl2pk5_RMcTlMnZl_pqSfs2LUblaj0qi2XLrdys7bjniY0XXxKBqmuSjTdZPh6QmzBnGb-WqLefV4JQxm1JZM4hFgIp4t2RmVAEbPwpWSCtS4z8eCRGYIGiwGGoIDkSBzvUoKzzv4HPPzmU1zal6d3_GM49cmeHROmHzuQ-ueHKB-TXZIuqrSsPlsclndbdsQda5fTs6ufVebFdU1NXrcwr3L5NkAH6jn51SO5wDf1YYAGuVoGAmjKjrQgJFj3ul1janWZoaFHSE6SE0KSo62XVFE3bYF4ui7S4bOjMIdXb0sStVnSBpYVy1wXrQ_J9OvmWzLxdGQfPBjyOPJMbw2JjTRxb3wFehIxQKJ77FqAp83MAJLHJpAoMJHepiySzFnCVdNJypVQaPCJHZVW6J4SiWg1LJQtSJoTJhbGMG-UAwkUAQ6Qakve96_SmU-vQmOWgzzX4XKPPtR9rocHnQ_IavKsvbKFRZBuv55W-qDWkEnMdA1RUIdj0vtcw8fBviildtW005JmhwoCB9zzuYmHfZx9KQ6IOomRvgP0dPoHgaMW9d8Hw9J9bviK3FsdTfTI__fyM3MYBd-yb5-Tost66F2TQZNuX7Wz5Da6IGQU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Eugenol-rich+Fraction+of+Syzygium+aromaticum+%28Clove%29+Reverses+Biochemical+and+Histopathological+Changes+in+Liver+Cirrhosis+and+Inhibits+Hepatic+Cell+Proliferation&rft.jtitle=Journal+of+cancer+prevention&rft.au=Ali%2C+Shakir&rft.au=Prasad%2C+Ram&rft.au=Mahmood%2C+Amena&rft.au=Routray%2C+Indusmita&rft.date=2014-12-01&rft.issn=2288-3649&rft.volume=19&rft.issue=4&rft.spage=288&rft.epage=300&rft_id=info:doi/10.15430%2FJCP.2014.19.4.288&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-3649&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-3649&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-3649&client=summon |